Gamma Glutamyl Transferase: Comprehensive Review
Whitfield JB • Crit Rev Clin Lab Sci
Key Finding
Established GGT as a key marker beyond alcohol detection
Original title: “Gamma glutamyl transferase”
Plain English Summary
This comprehensive review covers GGT's biochemistry, clinical significance, and role in detecting alcohol abuse. The author establishes reference ranges and discusses how GGT elevations relate to various liver conditions, medications, and metabolic disorders. The review became a foundational reference for interpreting GGT in clinical practice.
In-Depth Analysis
Background
Whitfield JB. Crit Rev Clin Lab Sci. 2001;38(4):263-355. PMID: 11563810
This comprehensive 93-page review represents the definitive clinical laboratory science reference on gamma-glutamyltransferase (GGT), covering biochemistry, clinical utility, and interpretation.
Study Design
| Parameter | Details |
|---|---|
| Type | Comprehensive scientific review |
| Scope | GGT biochemistry, physiology, clinical applications |
| Coverage | >500 referenced studies |
| Author | Leading Australian clinical biochemistry researcher |
Key Findings
| Application | Clinical Utility |
|---|---|
| Hepatobiliary disease | Most sensitive liver enzyme for cholestasis |
| Alcohol monitoring | Elevated in 50-70% of heavy drinkers |
| Oxidative stress | Reflects glutathione metabolism status |
| Metabolic syndrome | Early marker preceding diabetes diagnosis |
| Cardiovascular risk | Independent predictor of CVD mortality |
Reference ranges: Men <50 U/L, Women <32 U/L (though optimal likely lower).
Mechanistic Insights
GGT functions in glutathione recycling at cell membranes, making it a marker of oxidative stress. Elevated levels indicate increased antioxidant demand. The review details how GGT participates in amino acid transport and leukotriene metabolism.
Clinical Implications
Whitfield established that GGT elevation—even within "normal" range—is clinically significant and warrants investigation. The review shifted understanding of GGT from a simple alcohol marker to a multifaceted metabolic indicator.
Metabolic Health Perspective
This foundational review supports using GGT as part of comprehensive metabolic assessment. The GGT evaluator optimal threshold (<15-20 U/L) reflects levels associated with lowest disease risk rather than population-based reference ranges.
Paradigm Relevance
How this study applies to different clinical perspectives:
Standard Medical
Conventional clinical guidelines used by most doctors
Not directly relevant to this paradigm
Research Consensus
Current scientific understanding, often ahead of guidelines
Not directly relevant to this paradigm
Metabolic Optimization
Proactive targets for optimal health, not just disease absence
Not directly relevant to this paradigm
Study Details
- Type
- Review Article
Topic
Related Biomarkers
Calculate & Evaluate on Metabolicum
Related Studies
Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose-response meta-analysis
Kennedy OJ, Roderick P, Buchanan R, et al. • BMJ Open • 2017
Two additional daily cups of coffee: 35% HCC risk reduction (RR 0.65, 95% CI 0.59-0.72); caffeinated coffee: 27% reduction; decaffeinated: 14% reduction
Gamma-Glutamyltransferase: A Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease Risk
Koenig G, Seneff S • Dis Markers • 2015
Framingham: highest GGT quartile HR 1.67 for CVD, HR 2.54 for MetS; Austrian study: GGT >56 U/L men/>36 U/L women = 100% increased mortality risk
Contribution of Hepatitis B Virus Infection to Liver Cancer Risk
Loomba R, Yang HI, Su J, et al. • Gastroenterology • 2013
HBV infection significantly increases liver cancer risk